is sitagliptin a glp-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? These highlights do not include
Description
De mi az a GLP-1, mire hasznltk eredetileg, s mirt lehetsges fogyni ennek segtsgvel

22 Twice daily danuglipron, In a phase 2 study decreased HbA1c by 0.49% to 1.18% in a dose dependent manner, compared to 0.02% for placebo

Intima media thickness decreased statistically non-significantly by the GLP-1 based therapies

A 2025 University of Chicago found that although GLP-1s deliver impressive long-health improvements, their current prices far exceed accepted thresholds for cost -effectiveness, posing difficult choices for policymakers, insurers and patients, a report on the study reads

(PDF) Beaudoin, F.L., Kessler, R.C., Hwang, I., Lee, S., Sampson, N.A., An, X., Ressler, K.J., Koenen, K.C., McLean, S.A., the AURORA Study Group (2021)
Curr Psychiatry Rep
